Infectious Diseases (all articles)
Coccidioidomycosis: A Contemporary review.
3 Mar, 2022 | 08:20h | UTCCoccidioidomycosis: A Contemporary Review – Infectious Diseases and Therapy
Prescribing Nirmatrelvir–Ritonavir for Covid-19: How to recognize and manage drug–drug interactions.
2 Mar, 2022 | 09:01h | UTCRelated:
Pfizer antiviral pills may be risky with other medications – NBC News
Anticoagulation in Patients With COVID-19: JACC Review Topic of the Week.
2 Mar, 2022 | 09:03h | UTCCommentary: Review of Anticoagulation in Patients With COVID-19: Key Points – American College of Cardiology
SEOM clinical guidelines for the prophylaxis of infectious diseases in cancer patients.
2 Mar, 2022 | 08:51h | UTC
Wuhan market was epicenter of pandemic’s start, studies suggest.
2 Mar, 2022 | 08:59h | UTCWuhan market was epicentre of pandemic’s start, studies suggest – Nature
Related:
[Preprint] SARS-like viruses may jump from animals to people hundreds of thousands of times a year.
Did the coronavirus jump from animals to people twice? – Nature
The Origins of SARS-CoV-2: A Critical Review.
Fauci says natural origins theory of coronavirus is still the most likely.
Commentary on Twitter
A trio of new preprint research articles add to evidence that the #pandemic originated in #Wuhan’s massive Huanan Seafood Wholesale market, supporting a zoonotic origin story similar to that of HIV, Zika, and Ebola. https://t.co/LqvCXV6WYY
— Global Health NOW (@ghn_news) February 28, 2022
Guideline Update: Timing of elective surgery and risk assessment after SARS-CoV-2 infection – “The guidance remains that patients should avoid elective surgery within 7 weeks of infection, unless the benefits of doing so exceed the risk of waiting”.
1 Mar, 2022 | 08:58h | UTCTiming of elective surgery and risk assessment after SARS-CoV-2 infection: an update – Anaesthesia
Related:
Guideline: SARS‐CoV‐2 infection, COVID‐19 and timing of elective surgery
BJS commission on surgery and perioperative care post-COVID-19.
ASA Guidance: Preoperative testing for COVID-19 is essential, regardless of vaccination.
Position statement: Perioperative management of post-COVID-19 surgical patients.
[Preprint] Study shows significantly reduced effectiveness of the Pfizer vaccine in children 5 to 11 after the emergency of the Omicron variant.
1 Mar, 2022 | 08:54h | UTCCommentaries:
Pfizer Covid vaccine is less effective in kids 5 to 11, study finds – STAT
More mask mandates fall as poor COVID vaccine protection noted in young kids – CIDRAP
HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management.
1 Mar, 2022 | 08:30h | UTCHPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management – Nature Reviews Clinical Oncology (if the link is paywalled, try this one)
New CDC interim guidance recommends a 4-month Rifapentine-Moxifloxacin regimen to treat drug-susceptible pulmonary tuberculosis.
27 Feb, 2022 | 22:49h | UTCRelated:
Summary | WHO recommendations on the treatment of drug-resistant tuberculosis, 2020 update.
WHO Guideline: Screening for Tuberculosis Disease
New WHO Recommendations to Prevent Tuberculosis
CDC Guidelines for the Treatment of Latent Tuberculosis Infection
Guideline: Treatment of Drug-Resistant Tuberculosis
The Lancet Commission: Management of Multidrug-resistant and Incurable Tuberculosis
Regimens to Treat Multidrug-resistant Tuberculosis: Past, Present and Future Perspectives
Guidelines for the Management of TB in Adults Living with HIV
Commentary on Twitter
Clinicians: @CDC_TB released interim guidance on a new regimen to treat #TB disease. Learn more about the 4-month regimen containing rifapentine, moxifloxacin, isoniazid, and pyrazinamide for people with drug-susceptible pulmonary TB disease in the U.S.: https://t.co/eOcR34tYJu pic.twitter.com/EFGMwAwN7c
— MMWR (@CDCMMWR) February 25, 2022
CDC issues long-awaited new guidance on when to wear masks.
27 Feb, 2022 | 22:45h | UTCCDC issues long-awaited new guidance on when to wear masks – STAT
See also: As mask mandates fade, experts say use of masks likely will not – STAT
ESCMID COVID-19 guidelines: diagnostic testing for SARS-CoV-2.
27 Feb, 2022 | 22:47h | UTCESCMID COVID-19 guidelines: diagnostic testing for SARS-CoV-2 – Clinical Microbiology and Infection
Consensus on intraoperative technical/surgical aspects to prevent surgical site infection after colorectal surgery.
27 Feb, 2022 | 22:32h | UTC
Consensus Statement: Successfully implementing digital health to ensure future global health security during pandemics.
25 Feb, 2022 | 11:34h | UTC
At least 5 million children have lost a parent or caregiver due to COVID-19 since March 2020, updated figures suggest.
25 Feb, 2022 | 11:32h | UTCCommentaries:
Related:
More than 1.5 million children lost a primary or secondary caregiver due to the COVID-19 pandemic.
Covid-19 Has Created Thousands Of Newly Single Parents And Orphans
Commentary on Twitter (thread – click for more)
At least 5 million children have lost a parent or caregiver due to #COVID19 since March 2020, updated figures suggest.
Authors urge actions to prioritise affected children, incl. economic strengthening, enhanced community & family support, & education. https://t.co/1slpFhjDJd pic.twitter.com/AvEncg4Yx1
— The Lancet (@TheLancet) February 24, 2022
Study suggests multisystem inflammatory syndrome in children (MIS-C) is rare among vaccinated teens.
25 Feb, 2022 | 11:29h | UTCCommentaries:
When vaccine adverse event reporting generates hope, not fear – The Lancet Child & Adolescent Health
MIS-C rare in COVID-vaccinated teens, study finds – CIDRAP
Vaccination Greatly Reduces Odds of MIS-C in Teens Who Get COVID – HealthDay
Commentary on Twitter
New study from @CDCgov finds that multi-system inflammatory syndrome in children (#MISC) is rare among 12 to 20-year-olds who have received #COVID19 vaccination (1.0 case per million individuals receiving one or more doses)https://t.co/BpsXSpMMcH
— The Lancet Child & Adolescent Health (@LancetChildAdol) February 23, 2022
Editorial: Addressing vaccine inequity — Covid-19 vaccines as a global public good.
24 Feb, 2022 | 10:41h | UTC
Previous population immunity and Covid-19 severity with Omicron variant in South Africa.
24 Feb, 2022 | 10:43h | UTCAudio Interview: Understanding the Omicron Variant of SARS-CoV-2
Commentary on Twitter
In Gauteng, South Africa, where the omicron variant was first identified, two thirds of unvaccinated residents were seropositive for SARS-CoV-2, which indicates past infection. Omicron peaked just 1 month after being detected. #COVID19 https://t.co/Z8qTI1DNkv pic.twitter.com/ZZv2xevacG
— NEJM (@NEJM) February 23, 2022
RCT: Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine.
24 Feb, 2022 | 10:20h | UTCCommentary: Suspend Methotrexate for RA Patients Getting COVID Vax?— It’s not a simple choice, Brazilian study suggests (free registration required)
[Preprint] Fourth dose of COVID vaccine offers only slight boost against Omicron infection.
24 Feb, 2022 | 10:30h | UTCFourth dose of COVID vaccine offers only slight boost against Omicron infection – Nature
Original Study: 4th Dose COVID mRNA Vaccines’ Immunogenicity & Efficacy Against Omicron VOC – medRxiv
Two large populational-based studies find a slightly increased risk of thrombotic events following AstraZeneca COVID-19 vaccination.
24 Feb, 2022 | 10:23h | UTCCommentaries:
Two Large Studies Affirm Rare Thrombosis Risk With ChAdOx1 COVID-19 Vax – TCTMD
Mortality from congenital Zika Syndrome — nationwide cohort study in Brazil.
24 Feb, 2022 | 10:18h | UTC
M-A: Diagnostic accuracy of point-of-care tests in acute community-acquired lower respiratory tract infections.
23 Feb, 2022 | 10:07h | UTC
Meta-analysis finds low risk of a second allergic reaction to SARS-CoV-2 mRNA vaccines in patients with an allergic reaction with the first dose.
22 Feb, 2022 | 10:05h | UTC
Commentary on Twitter
Systematic review and meta-analysis of 22 studies and 1366 patients found that there was a low risk of repeat allergic reaction to a second #COVID19 mRNA vaccine dose in people who had immediate allergic reaction with the first dose. https://t.co/NQSXBJwa6r
— JAMA Internal Medicine (@JAMAInternalMed) February 21, 2022
UK unveils game plan for ‘living with COVID’.
22 Feb, 2022 | 09:56h | UTCUK unveils game plan for ‘living with COVID’ – CIDRAP
See also:
All you need to know about the end of Covid rules in England – The Guardian
‘Living with Covid’ strategy could do more harm than good, say businesses and unions – The Guardian
Opinion by Dr. Eric Topol | Why one-shot after a Covid-19 infection should suffice to be considered fully-vaxxed.
22 Feb, 2022 | 10:07h | UTCWhy one-shot after a Covid-19 infection should suffice to be considered fully-vaxxed – The Guardian
Commentary from the author on Twitter (thread – click for more)
My new essay @guardian
"Why one-shot after a Covid-19 infection should suffice to be considered fully-vaxxed"https://t.co/RaBUpET2CZ
Summarizes extensive new evidence that confirmed Prior Covid ("Natural Immunity" or NI) + 1-shot is as protective as 3-shots /1— Eric Topol (@EricTopol) February 20, 2022